What Independent Dental Owners Get Wrong About Valuation Before a DSO Sale
Many dental practice owners enter DSO acquisition talks with an inflated or incomplete sense of value. Here is what the math actually looks like heading into 2025.
If you have spent any time in dental practice ownership over the past five years, you have probably fielded a call from a DSO aggregator or a PE-backed platform. The pitch usually arrives with flattering language about your patient base and a headline multiple that sounds generous. What does not arrive, at least not upfront, is the fine print that determines whether that multiple translates into actual proceeds at closing.
Acquisition activity in dental group practices has remained active despite tighter credit markets. The American Dental Association's Health Policy Institute reported in 2023 that DSO-affiliated dentists represented roughly 11 percent of the active dentist workforce, a share that has grown steadily each year since 2017. That consolidation pressure has not slowed materially, even as interest rates climbed, because many larger platforms are deploying equity rather than debt to complete add-on acquisitions. For more on the topic discussed above, see Medical Practice Press.
EBITDA Adjustments Are Where Deals Get Complicated
The valuation conversation almost always starts with a multiple of EBITDA, typically somewhere between four and eight times for a single-location general practice, with specialty practices like oral surgery or orthodontics commanding higher figures in some markets. But that headline number obscures how aggressively buyers recast the income statement before they apply the multiple.
Common adjustments that reduce seller EBITDA include: owner compensation normalized to a market-rate associate salary, discretionary expenses added back inconsistently, rent assessed at fair market value if you own your building and have been paying yourself below-market lease rates, and deferred capital expenditures the buyer plans to address post-close. A practice showing $400,000 in reported EBITDA can land at $310,000 or lower after adjustments, which at a six-times multiple represents a $540,000 difference in enterprise value before any rollover equity or earnout is factored in.
Rollover equity is worth a separate conversation. Many DSO deals ask sellers to roll 20 to 30 percent of their proceeds back into the platform in exchange for equity. That structure benefits sellers if the platform exits at a higher multiple in a future transaction, but it also means a portion of your proceeds is illiquid and tied to a business you no longer control. Understanding the platform's capitalization, debt load, and realistic exit timeline matters as much as the initial multiple.
What to Do Before You Take the Meeting
The practical preparation most sellers skip is hiring a qualified business appraiser or dental-specific M&A advisor before they enter any letter-of-intent conversation. The Healthcare Financial Management Association publishes guidance on valuation standards applicable to medical and dental practices; that framework is a reasonable starting point for understanding whether an incoming offer reflects market norms or opportunistic pricing.
Pull three years of tax returns and profit-and-loss statements, reconcile your accounts receivable aging, and document any equipment that will need replacement within 24 months. Buyers already know this information or will find it in due diligence. Knowing it first means you negotiate from a position of accuracy rather than surprise.